Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep 15:2023:5596890.
doi: 10.1155/2023/5596890. eCollection 2023.

Intravascular Large B-Cell Lymphoma

Affiliations
Case Reports

Intravascular Large B-Cell Lymphoma

Mehdi Loukhnati et al. Case Rep Hematol. .

Abstract

Intravascular large B-cell lymphoma (IVBCL) is a very rare and aggressive subtype of extranodal diffuse large B-cell lymphoma (DLBCL) involving the growth of lymphoma cells within blood vessels of all organ types. We present the case of a 55-year-old North-African man with no prior history of neoplastic disease presenting with weight loss and an isolated splenomegaly. Investigations led to the diagnosis of this disease. To the best of our knowledge, this is the first case recorded in Africa. Through this article, we discuss this case and outline the common presentation, paraclinical investigations, and treatment options of IVBCL.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Bone marrow biopsy: palisade arrangement of atypical cells mixed with red blood cells within the vessels.
Figure 2
Figure 2
PET scan showing bone marrow and spleen hypermetabolism.

References

    1. Pfleger L., Tappeiner J. On the recognition of systematized endotheliomatosis of the cutaneous blood vessels (reticuloendotheliosis?] Hautarzt, Der . 1959;10:359–363. - PubMed
    1. Geer M., Roberts E., Shango M., et al. Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. British Journal of Haematology . 2019;186(2):255–262. doi: 10.1111/bjh.15923. - DOI - PMC - PubMed
    1. Alaggio R., Amador C., Anagnostopoulos I., et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia . 2022;36(7):1720–1748. doi: 10.1038/s41375-022-01620-2. - DOI - PMC - PubMed
    1. Ferreri A. J., Campo E., Seymour J. F., Willemze R., Ilariucci F. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1: intravascular Lymphoma. British Journal of Haematology . 2004;127(2):173–183. doi: 10.1111/j.1365-2141.2004.05177.x. - DOI - PubMed
    1. Murase T., Nakamura S., Tashiro K., et al. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: a report of five cases and review of the literature. British Journal of Haematology . 1997;99(3):656–664. doi: 10.1046/j.1365-2141.1997.4623265.x. - DOI - PubMed

Publication types